ChromaCode Raises $12 Million in Series B for Commercial Launch and Appoints Alex Dickinson as Executive ChairApril 27, 2017
Dr. Alex Dickinson joins the executive team, bringing broad experience in global cloud services and reagent solutions for high-throughput molecular diagnostics.
Platform Presentation of Phase 2 Data in Fragile X Syndrome
Milestone Pharmaceuticals to Present Etripamil Phase 2 Data at the Heart Rhythm Society's 38th Annual Scientific SessionsApril 12, 2017
Data from NODE-1 Trial to be Presented as Part of Late Breaking Oral Session May 11th